We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

4 hedge funds and large institutions have $315K invested in Cyclo Therapeutics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 2 → 4 (+2)

38% more capital invested

Capital invested by funds: $228K → $315K (+$87K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
–
Calls
$1.1M
Puts
–
Net Calls
+$1.1M
Net Calls Change
+$1.1M

Top Buyers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
-$33.6K
2
UBS Group
UBS Group
Switzerland
-$1.44K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Empery Asset Management
New York
$163K +$157K +65,000 New
WVP
2
Worth Venture Partners
New Jersey
$149K -$33.6K -13,954 -16%
UBS Group
3
UBS Group
Switzerland
$3K -$1.44K -596 -29%
Verition Fund Management
4
Verition Fund Management
Connecticut
– +$1.93M +800,000 New

CYTHW Hedge Fund Activity: Q4 2021 in Review

4 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q4 2021, worth a combined $315K — up 38% from $228K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CYTHW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Verition Fund Management, opening a new position worth an estimated $1.93M. The largest seller was Worth Venture Partners, cutting an estimated $33.6K.

  • 4 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q4 2021, up from 2 in Q3 2021.
  • Funds reported $315K of Cyclo Therapeutics, Inc. Warrant stock for Q4 2021, up 38% quarter-over-quarter.
  • 2 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q4 2021 and 0 closed out, a net change of +2 holders.
  • The largest Cyclo Therapeutics, Inc. Warrant buyer in Q4 2021 was Verition Fund Management, an estimated $1.93M added.
  • The largest Cyclo Therapeutics, Inc. Warrant seller in Q4 2021 was Worth Venture Partners, an estimated $33.6K sold.

Based on aggregated 13F filings for Q4 2021.